Drug candidates in clinical trials for Alzheimer’s disease
Abstract Alzheimer’s disease (AD) is a major form of senile dementia, characterized by progressive memory and neuronal loss combined with cognitive impairment. AD is the most common neurodegenerative disease worldwide, affecting one-fifth of those aged over 85 years. Recent therapeutic approaches ha...
Main Authors: | Shih-Ya Hung, Wen-Mei Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12929-017-0355-7 |
Similar Items
-
Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
by: Yuxia Cao, et al.
Published: (2022-11-01) -
Role of Cholinergic Signaling in Alzheimer’s Disease
by: Zhi-Ru Chen, et al.
Published: (2022-03-01) -
Clinical Trial Design in Alzheimer's Disease
by: Seyed Mehrdad Savar, et al.
Published: (2022-06-01) -
Clinical trials of new drugs for Alzheimer disease
by: Li-Kai Huang, et al.
Published: (2020-01-01) -
The “rights” of precision drug development for Alzheimer’s disease
by: Jeffrey Cummings, et al.
Published: (2019-08-01)